| Literature DB >> 29120456 |
A Summers1, M O Visscher2, S K Khatry3, J B Sherchand4, S C LeClerq1,3, J Katz1, J M Tielsch5, L C Mullany1.
Abstract
OBJECTIVE: The objective of this study was to determine the skin barrier changes during postnatal month 1 among infants receiving routine mustard oil massage in the humid conditions of rural Nepal. STUDYEntities:
Mesh:
Substances:
Year: 2017 PMID: 29120456 PMCID: PMC5775032 DOI: 10.1038/jp.2017.158
Source DB: PubMed Journal: J Perinatol ISSN: 0743-8346 Impact factor: 2.521
Baseline newborn characteristics of neonates by gestational age groups, Sarlahi, Nepal
| Gestational Age | ||||
|---|---|---|---|---|
|
| ||||
| <34 Weeks | 34–36 Weeks | ≥37 Weeks | Total | |
|
| ||||
| Characteristic | No. (%) | No. (%) | No. (%) | No. (%) |
| N=56 | N=148 | N=294 | N=500 | |
| Male | 32 (57.1) | 73 (49.3) | 162 (55.1) | 269 (53.8) |
| Female | 24 (42.9) | 75 (50.7) | 132 (44.9) | 231 (46.2) |
|
| ||||
| N=54 | N=148 | N=294 | N=498 | |
| <1500 | 4 (7.4) | 1 (0.7) | 1 (0.3) | 6 (1.2) |
| 1500–2499 | 20 (37.0) | 58 (39.2) | 83 (28.2) | 161 (32.3) |
| ≥2500 | 30 (55.6) | 89 (60.1) | 210 (71.4) | 331 (66.5) |
|
| ||||
| N=54 | N=148 | N=269 | N=471 | |
| AGA | 51 (94.4) | 128 (86.5) | 133 (49.4) | 312 (66.2) |
| SGA 3–10% | 3 (5.6) | 11 (7.4) | 56 (20.8) | 70 (14.9) |
| SGA 3% | 0 (0) | 9 (6.1) | 80 (29.7) | 89 (18.9) |
|
| ||||
| N=245 | N=696 | N=1343 | N=2293 | |
| <30 | 46 (18.9) | 154 (22.1) | 293 (21.8) | 497 (21.7) |
| 30–59 | 36 (14.7) | 139 (20.0) | 237 (17.7) | 413 (18.0) |
| 60–119 | 67 (27.4) | 145 (20.8) | 312 (23.2) | 526 (22.9) |
| 120–179 | 32 (13.1) | 92 (13.2) | 185 (13.8) | 309 (13.5) |
| ≥180 | 64 (26.1) | 166 (23.9) | 316 (23.5) | 548 (23.9) |
|
| ||||
|
| ||||
| 2511.7 (545) | 2527 (434) | 2717 (406) | 2638 (440) | |
| 31.3 (2.6) | 35.8 (0.8) | 40.2 (2.0) | 37.9 (3.6) | |
| 4.6 (1.4) | 4.8 (1.4) | 4.6 (1.4) | 4.6 (1.4) | |
Small for Gestational Age
Adequate for Gestational Age
Skin barrier integrity measures of neonates at five time points during the neonatal period, Sarlahi, Nepal
| Skin Barrier Integrity Measure | Visit Number
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 3 | 7 | 14 | 28 | ||||||
|
| ||||||||||
| N | Mean (SD | N | Mean (SD) | N | Mean (SD) | N | Mean (SD) | N | Mean (SD) | |
| Erythema Score, Chest
| 500 | 0.46 (0.61) | 480 | 0.73 (0.63) | 474 | 0.68 (0.59) | 464 | 0.74 (0.63) | 394 | 0.49 (0.54) |
| Erythema Score, Arm
| 500 | 0.55 (0.67) | 480 | 0.77 (0.63) | 474 | 0.80 (0.58) | 464 | 0.90 (0.63) | 394 | 0.61 (0.53) |
| Erythema Score, Leg
| 500 | 0.57 (0.68) | 480 | 0.74 (0.65) | 474 | 0.78 (0.61) | 464 | 0.82 (0.62) | 394 | 0.63 (0.59) |
| Rash Score, Chest
| 500 | 0.13 (0.39) | 480 | 0.67 (0.76) | 474 | 0.72 (0.77) | 464 | 0.97 (0.79) | 394 | 0.66 (0.70) |
| Rash Score, Arm
| 500 | 0.17 (0.47) | 480 | 0.65 (0.76) | 474 | 0.93 (0.84) | 464 | 1.18 (0.87) | 394 | 0.74 (0.72) |
| Rash Score, Leg
| 500 | 0.15 (0.44) | 480 | 0.52 (0.70) | 474 | 0.71 (0.78) | 464 | 0.98 (0.78) | 394 | 0.74 (0.74) |
| Dryness Score, Chest
| 500 | 0.002 (0.03) | 480 | 0.010 (0.16) | 474 | 0.017 (0.20) | 464 | 0.050 (0.37) | 394 | 0 |
| Dryness Score, Arm
| 500 | 0.004 (0.07) | 480 | 0.067 (0.40) | 474 | 0.16 (0.65) | 464 | 0.15 (0.64) | 394 | 0.020 (0.20) |
| Dryness Score, Leg
| 500 | 0.01 (0.15) | 480 | 0.027 (0.23) | 474 | 0.12 (0.56) | 464 | 0.039 (0.31) | 394 | 0.024 (0.26) |
| Skin pH
| 498 | 6.09 (0.53) | 480 | 5.72 (0.53) | 472 | 5.33 (0.58) | 459 | 5.20 (0.57) | 389 | 5.00 (0.61) |
| TEWL | 499 | 33.2 (23.5) | 480 | 36.1 (24.7) | 468 | 37.7 (24.5) | 458 | 40.7 (24.3) | 386 | 43.0 (24.5) |
| Protein concentration (μg/cm2) | 497 | 16.6 (7.88) | N/A | N/A | 473 | 13.3 (6.52) | 460 | 13.4 (6.96) | 391 | 13.5 (5.89) |
Standard deviation;
Transepidermal water loss
Figure 1Lowess curves of the change in chest skin condition throughout the neonatal period by gestational age groups, Sarlahi, Nepal
Bivariate random-effects model comparing skin integrity measures throughout the entire study period by gestational age group, Sarlahi, Nepal
| Skin Barrier Integrity Measure | Gestational Age | |||
|---|---|---|---|---|
| 34–36 Weeks | ≥37 Weeks | |||
| β | 95%CI | β | 95%CI | |
| Erythema, Chest | 0.03 | −0.09–0.15 | −0.01 | −0.11–0.12 |
| Erythema, Arm | 0.04 | −0.09–0.17 | 0.04 | −0.08–0.16 |
| Erythema, Leg | 0.03 | −0.10–0.16 | −0.002 | −0.13–0.12 |
| Rash, Chest | 0.03 | −0.10–0.16 | 0.07 | −0.06–0.19 |
| Rash, Arm | 0.05 | −0.10–0.19 | 0.11 | −0.02–0.25 |
| Rash, Leg | −0.02 | −0.14–0.11 | 0.05 | −0.07–0.17 |
| Dryness, Chest | −0.03 | −0.05–0.004 | −0.01 | −0.04–0.01 |
| Dryness, Arm | −0.02 | −0.09–0.05 | −0.01 | −0.07–0.06 |
| Dryness, Leg | 0.01 | −0.04–0.06 | 0.02 | −0.03–0.06 |
| Skin pH | −0.19 | −0.32–−0.06 | −0.08 | −0.20–0.04 |
| TEWL | 2.13 | −3.39–7.66 | 2.63 | −3.10–7.22 |
| Protein concentration (μg/cm2) | −1.33 | −2.60–−0.06 | −0.89 | −2.07–0.30 |
Reference Group: Gestational age <34 weeks;
Confidence Interval;
Transepidermal water loss
Figure 2Lowess curves of the change in skin pH, SC protein concentration, and TEWL throughout the neonatal period by gestational age groups, Sarlahi, Nepal